Teknimed
PrivateLast Round
Buyout/LBO
Jul 2, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Teknimed is a biotechnology company that develops, manufactures, and distributes orthopaedic bone cements, synthetic bone substitutes, and other biomaterials for surgical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teknimed Comparables
Compare Teknimed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OSARTIS GmbH | 87% | |
| Biocomposites | 86% | |
| Tecres | 85% |
Teknimed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jul 2, 2026 | ||||
| Buyout/LBO | Nov 9, 2021 | ||||
| Buyout/LBO | Jun 1, 2015 |
Teknimed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bourrelier Group | Buyout/LBO |
| Seven2 | Buyout/LBO |
| Apheon | Buyout/LBO |
| Bpifrance | Buyout/LBO |
| Multicroissance | Buyout/LBO |
| Crédit Mutuel Equity | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Apheon led the buyout round.
- Nov 9, 2021
Essling Expansion led the round with participation from Bourrelier Group and Multicroissance.
Teknimed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Teknimed's valuation, stock price, and market status.
Is Teknimed a public or private company?
Teknimed is a private company.
What is the current stock price of Teknimed?
Teknimed is a private company with no public stock price. No recent secondary market data is available.
How much is Teknimed worth (valuation)?
Valuation information for Teknimed is not publicly available.
Can I buy Teknimed stock?
Teknimed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Teknimed's last funding round?
Teknimed's most recent funding round was Buyout/LBO on July 2, 2026.
Who are the main investors in Teknimed?
Key investors in Teknimed include Seven2, Apheon.
Will Teknimed IPO soon?
No public IPO plans have been announced for Teknimed.
How can I track Teknimed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Teknimed's secondary market activity and sign up for updates.